Cancer risk with JAK inhibitors versus TNF inhibitors

被引：0
|
作者：
Thorley, Jennifer
机构：
来源：
LANCET RHEUMATOLOGY | 2023年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e252 / e252
页数：1
相关论文
共 50 条
  • [31] TNF inhibitors versus DMARDs for rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (09): : E526 - E526
  • [32] TNF inhibitors plus cyclophosphamide could increase patients' cancer risk
    Nature Clinical Practice Rheumatology, 2006, 2 (8): : 404 - 404
  • [33] TNF inhibitors plus cyclophosphamide could increase patients' cancer risk
    Nature Clinical Practice Oncology, 2006, 3 (8): : 414 - 415
  • [34] Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in patients with rheumatoid arthritis who discontinued JAK inhibitor therapy
    Andrea, Amstad
    Eleftherios, Papagiannoulis
    Almut, Scherer
    Andrea, Rubbert-Roth
    Axel, Finckh
    Ruediger, Mueller
    Jean, Dudler
    Burkhard, Moller
    Peter, Villiger M.
    Martin, Schulz M. P.
    Diego, Kyburz
    SWISS MEDICAL WEEKLY, 2022, 152 : 5S - 5S
  • [35] TNF-α and its inhibitors in cancer
    Zidi, Ines
    Mestiri, Souhir
    Bartegi, Aghleb
    Ben Amor, Nidhal
    MEDICAL ONCOLOGY, 2010, 27 (02) : 185 - 198
  • [36] TNF-α and its inhibitors in cancer
    Inès Zidi
    Souhir Mestiri
    Aghleb Bartegi
    Nidhal Ben Amor
    Medical Oncology, 2010, 27 : 185 - 198
  • [37] Risk of Cardiovascular Events, Malignancy, and Serious Infection Associated with JAK Inhibitors and TNF Inhibitors in Rheumatoid Arthritis or Ulcerative Colitis: A Nationwide Cohort Study
    Cho, Yongtai
    Yoon, Dongwon
    Khosrow-Khavar, Farzin
    Song, Minkyo
    Kim, Ju Hwan
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 9 - 9
  • [38] Combining JAK Inhibitors with Immune Checkpoint Inhibitors: Overcoming Resistance in Cancer Treatment
    Zhong, Hai-Jing
    MEDCOMM, 2025, 6 (03):
  • [39] JAK inhibitors and black box warnings: what is the future for JAK inhibitors?
    Tokareva, Kate
    Reid, Pankti
    Yang, Victor
    Liew, David
    Peterson, Alexander C.
    Baraff, Aaron
    Giles, Jon
    Singh, Namrata
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (11) : 1385 - 1397
  • [40] JAK inhibitors and infections risk: focus on herpes zoster
    Sunzini, Flavia
    McInnes, Iain
    Siebert, Stefan
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2020, 12
12345